Expression of BCR-ABL, E2A-PBX1, and MLL-AF4 fusion transcripts in newly diagnosed children with acute lymphoblastic leukemia: A Children's Cancer Group initiative

Leukemia and Lymphoma

Volumn 26, Issue 1-2, 1997, Pages 57-65

  Gaynon, Paul S ^a,h   Crotty, Mya Lisa ^b   Sather, Harland N ^c   Bostrom, Bruch C ^d   Nachman, James B ^e   Steinherz, Peter G ^f   Heerema, Nyla A ^g   Sarquis, Mireille ^b   Tuel Ahlgren, Lisa ^b   Uckun, Fatih M ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Children's Cancer Study Group   (United States)

^d CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g INDIANA UNIVERSITY   (United States)

^h K4/430 CSC ^*  (United States)

Author keywords

ALL; BCR Abl; Childhood leukemia; E2A PBX1; Fusion transcripts acute lymphoblastic leukemia; MLL AF4

Indexed keywords

BCR ABL PROTEIN; HYBRID PROTEIN; MESSENGER RNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE; ARTICLE; BONE MARROW CELL; CANCER GENETICS; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; GENE FUSION; HEPATOMEGALY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT FAILURE;

EID: 8544230645     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709109158     Document Type: Article

References (29)

1. Cortes, J E. and Kantarjian, H. M. (1995). Acute lymphoblastic leukemia, Cancer, 76, 2393-2417.
2. Pui, C -H., Crist, W. M. and Look, A. T. (1990). Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia, Blood, 76, 1449-1463.
3. Raimondi, S. C., Privitera, E., Williams, D L., Look, A. T., Behm, F., Rivera, G. K., Crist, W. M. and Pui, C.-H (1991). New recurring chromosomal translocations in childhood acute lymphoblastic leukemia, Blood, 77, 2016-2022.
4. Trueworthy, R., Shuster, J., Look, T., Crist, W., Borowitz, M., Carroll, A., Frankel, L , Harris, M , Wagner, H., Haggard, M., Mosijczuk, A., Pullen, J., Steuber, P. and Land, V (1992). Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: A Pediatric Oncology Group study, J Clin Oncol, 10, 606-613
5. Pui, C -H., Carroll, A. J., Raimondi, S. C., Land, V. J., Crist, W. M., Shuster, J. J., Williams, D. L., Pullen, D. J., Borowitz, M. J., Behm, F. G. and Look, A. T. (1990). Clinical presentation, karyotypic characterization, and treatment outcome of childhood acute lymphoblastic leukemia with a near-haploid or hypodiploid <45 line, Blood, 75, 1170-1177.
6. Crist, W. M., Carroll, A. J., Shuster, J. J., Behm, F. G., Whitehead, M., Vietti, T. J., Look, A. T . Mahoney, D , Ragab, A., Pullen, D. J. and Land, V J. (1990). Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19) (q23;p13): a Pediatric Oncology Group Study, Blood, 76, 117-122.
7. Raimondi, S. C., Behm, F. G., Roberson, P. K., Williams, D. L., Pui, C.-H., Crist, W. M., Look, A. T and Rivera, G. K. (1990). Cytogenetics of pre-B acute lymphoblastic leukemia with emphasis on prognostic implications of the t( 1;19), J Clin Oncol, 8, 1380-1388.
8. Pui, C -H., Raimondi, S. C., Hancock, M. L., Rivera, G. K., Ribeiro, R. V., Mahmoud, H H., Sandlund, J. T., Crist, W. M. and Behm, F. G. (1994). Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19)(q23;p13) or its derivative, J Clin Oncol, 12, 2601-2606.
9. Privitera, E., Luciano, A., Ronchetti, D , AricoÓ, M., Santostasi, T., Basso, G. and Biondi, A. (1994). Molecular variants of the 1;19 chromosomal translocation in pediatric acute lymphoblastic leukemia (ALL), Leukemia, 8, 554-559.
10. Hunger, S. P. (1996). Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis. Blood, 87, 1211-1224.
11. Pui, C.-H., Frankel, L. S., Carroll, A. J., Raimondi, S. C., Shuster, J. J., Head, D. R., Crist, W. M., Land, V. J., Pullen, D. J., Steuber, C. P., Behm, F. G. and Borowitz, M. J. (1991). Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4:11)(q21;q23): A collaborative study of 40 cases. Blood, 77, 440-447.
12. Pui, C. H., Carroll. A. J., Raimondi, S. C., Shusterr, J. J., Crist, W. M. and Pullen, J. D. (1993). Childhood acute lymphoblastic leukemia with the t(4;11) (q21;q23): an update, Blood, 83, 2384-2385.
13. Heerema, N. A., Arthur, D. C., Sather, H., Albo, V., Feusner, J., Lange, B. J., Steinherz, P. G., Zeltzer, P., Hammond, D. and Reaman, G. H. (1994). Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Childrens Cancer Group, Blood, 83, 2274-2284.
14. Morrissey, J., Tkachuk, D. C., Milatovich, A., Francke, U., Link, M. and Cleary, M. L. (1993) A serine/proline-rich protein is fused to HRX in t(4:11) acute leukemia, Blood, 81, 1124-1131.
15. Crist, W., Carroll, A., Shuster, J., Jackson, J., Head, D., Borowitz, M., Behm, F., Link, M., Steuber, P., Ragab, A., Hirt, A., Brock, B., Land, V. and Pullen, J. (1990). Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study, Blood, 76, 489-494.
16. Fletcher, J. A., Lynch, E A., Kimball, V. M., Donnelly, M., Tantravahi, R. and Sallan, S. E. (1991). Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia, Blood, 77, 435-439.
17. Russo, C , Carroll, A , Kohler, S , Borowitz, M., Amylon, M., Homans, A., Kedar, A., Shuster, J., Land, V., Crist, W., Pullen, J. and Link, M. (1991). Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: A Pediatric Oncology Group study, Blood, 77, 1050-1056.
18. Campana, D. and Pui, C.-H. (1995). Detection of minimal residual disease in acute leukemia: Methodologic advances and clinical significance, Blood, 85, 1416-1434.
19. Maurer, J., Janssen, J. W. G , Thiel, E., van Denderen, J., Ludwig, W.-D., Aydemir, Ü., Heinze, B., Fonatsch, C., Harbott, J., Reiter, A., Riehm, H., Hoelzer, D and Bartram, C. R. (1991). Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction, Lancet, 337, 1055-1058.
20. Izraeli, S., Janssen, J. W. G., Haas, O. A , Harbott, J., Brok- Simoni, F., Walther, J. U., Kovar, H., Henn, T., Ludwig, W.- D., Reiter, A., Rechavi, G., Bartram, C. R., Gadner, H. and Lion, T. (1993). Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: A comparison between cytogenetic and polymerase chain reaction analyses. Leukemia, 7, 671-678.
21. Romana, S. P., Poirel, H., Leconiat, M., Flexor, M. A., Mauchauffé, M., Jonveaux, P., Macintyre, E. A., Berger, R., Bernard, O. A. (1995). High frequency of t(12:21) in childhood B-lineage acute lymphoblastic leukemia, Blood, 86, 4263-4269\.
22. Shurtleff, S. A., Buijs, A., Behm, F G , Rubnitz, J. E., Raimondi, S. C., Hancock, M. L., Chan, G. C. F., Pui, C. H., Grosveld, G. and Downing, J. R. (1995). TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis, Leukemia, 9, 1985-1989.
23. Uckun, F. M., Downing, J. R., Gunther, R., Chelstrom, L. M., Finnegan, D., Land, V. J., Borowitz, M J., Carroll, A. J. and Crist, W. M. (1993). Human t(1;19) (q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency. Blood, 81, 3052-3062.
24. Uckun, F. M., Downing, J. R., Chelstrom, L. M., Gunther, R., Ryan, M., Simon, J., Carroll, A. J., Tuel-Ahlgren, L. and Crist, W. M. (1994). Human t(4:11 1) (q21;q23) acute lymphoblastic leukemia in mice with severe combined immunodeficiency, Blood, 83, 859-865.
25. Mantel, N. (1966). Evaluation of survival data and two new rank order statistics arising in its consideration, Cancer Chemother Rep, 50, 163-170.
26. Peto, R , Pike, M. C., Armitage, P , et al. (1977). Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples, Br J Cancer, 35, 1-39
27. Breslow, N. (1975). Analysis of survival data under the proportional hazards model, Int Stat Rev, 43, 45-58.
28. Mastrangelo, R., Poplack, D., Bleyer, A., Riccardi, R., Sather, H. and D'Angio, G. (1986). Report and recommendations of the Rome Workshop concerning poor-prognosis acute lymphoblastic leukemia in children: Biologic bases for staging, stratification, and treatment. Med Pediatr Oncol, 14, 191-194.
29. Smith, M., Arthur, D., Camitta, B., Carroll, A. J., Crist, W., Gaynon, P., Gelber, R., Heerema, N., Korn, E. L., Link, M , Murphy, S., Pui, C. H., Pullen, J., Reaman, G., Sallan, S. E., Sather, H., Shuster, J., Simon, R., Trigg, M., Tubergen, D., Uckun, F. and Ungeleider, R. (1996) Uniform approach to the risk classification and treatment assignment for children with acute lymphoblastic leukemia, J Clin Oncol, 14, 18-24.